Boston Scientific Quick Ratio 2010-2025 | BSX
Historical quick ratio values for Boston Scientific (BSX) over the last 10 years.
| Boston Scientific Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2025-03-31 | $4.47B | $5.06B | 0.88 |
| 2024-12-31 | $4.11B | $6.40B | 0.64 |
| 2024-09-30 | $6.01B | $5.91B | 1.02 |
| 2024-06-30 | $6.38B | $5.58B | 1.15 |
| 2024-03-31 | $5.62B | $4.92B | 1.14 |
| 2023-12-31 | $4.03B | $4.93B | 0.82 |
| 2023-09-30 | $4.10B | $4.58B | 0.90 |
| 2023-06-30 | $3.64B | $4.56B | 0.80 |
| 2023-03-31 | $3.65B | $4.08B | 0.90 |
| 2022-12-31 | $3.89B | $3.80B | 1.02 |
| 2022-09-30 | $3.36B | $3.55B | 0.95 |
| 2022-06-30 | $3.33B | $3.88B | 0.86 |
| 2022-03-31 | $3.33B | $4.28B | 0.78 |
| 2021-12-31 | $4.71B | $4.27B | 1.10 |
| 2021-09-30 | $4.63B | $4.02B | 1.15 |
| 2021-06-30 | $5.33B | $4.07B | 1.31 |
| 2021-03-31 | $4.69B | $3.39B | 1.38 |
| 2020-12-31 | $5.34B | $3.68B | 1.45 |
| 2020-09-30 | $4.69B | $3.30B | 1.42 |
| 2020-06-30 | $4.29B | $3.11B | 1.38 |
| 2020-03-31 | $3.20B | $3.98B | 0.80 |
| 2019-12-31 | $3.12B | $4.87B | 0.64 |
| 2019-09-30 | $3.28B | $4.25B | 0.77 |
| 2019-06-30 | $5.03B | $4.85B | 1.04 |
| 2019-03-31 | $5.01B | $4.48B | 1.12 |
| 2018-12-31 | $2.84B | $5.26B | 0.54 |
| 2018-09-30 | $2.84B | $5.08B | 0.56 |
| 2018-06-30 | $2.84B | $4.75B | 0.60 |
| 2018-03-31 | $2.97B | $4.99B | 0.60 |
| 2017-12-31 | $2.74B | $5.65B | 0.49 |
| 2017-09-30 | $2.40B | $4.83B | 0.50 |
| 2017-06-30 | $2.20B | $4.30B | 0.51 |
| 2017-03-31 | $2.06B | $3.49B | 0.59 |
| 2016-12-31 | $2.28B | $3.59B | 0.64 |
| 2016-09-30 | $2.18B | $3.02B | 0.72 |
| 2016-06-30 | $2.35B | $3.18B | 0.74 |
| 2016-03-31 | $2.14B | $2.61B | 0.82 |
| 2015-12-31 | $2.46B | $2.43B | 1.01 |
| 2015-09-30 | $2.38B | $2.24B | 1.06 |
| 2015-06-30 | $2.81B | $1.94B | 1.45 |
| 2015-03-31 | $2.23B | $2.46B | 0.91 |
| 2014-12-31 | $2.66B | $2.85B | 0.94 |
| 2014-09-30 | $2.19B | $1.82B | 1.20 |
| 2014-06-30 | $2.27B | $1.77B | 1.28 |
| 2014-03-31 | $2.01B | $1.72B | 1.17 |
| 2013-12-31 | $2.11B | $1.82B | 1.16 |
| 2013-09-30 | $2.63B | $1.90B | 1.38 |
| 2013-06-30 | $2.66B | $2.48B | 1.07 |
| 2013-03-31 | $2.25B | $1.64B | 1.38 |
| 2012-12-31 | $2.14B | $1.77B | 1.21 |
| 2012-09-30 | $2.26B | $1.82B | 1.25 |
| 2012-06-30 | $2.21B | $1.79B | 1.23 |
| 2012-03-31 | $2.20B | $1.67B | 1.32 |
| 2011-12-31 | $2.17B | $1.81B | 1.20 |
| 2011-09-30 | $2.24B | $1.89B | 1.19 |
| 2011-06-30 | $2.22B | $1.89B | 1.17 |
| 2011-03-31 | $2.67B | $2.04B | 1.31 |
| 2010-12-31 | $2.72B | $2.61B | 1.04 |
| 2010-09-30 | $2.63B | $2.96B | 0.89 |
| 2010-06-30 | $3.10B | $3.72B | 0.83 |
| 2010-03-31 | $2.84B | $2.91B | 0.98 |
| 2009-12-31 | $3.71B | $3.02B | 1.23 |
| 2009-09-30 | $4.02B | $3.18B | 1.27 |
| 2009-06-30 | $3.92B | $2.75B | 1.43 |
| 2009-03-31 | $3.72B | $2.43B | 1.53 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $154.617B | $16.747B |
| Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.693B | 27.62 |
| Stryker (SYK) | United States | $145.191B | 30.36 |
| EssilorLuxottica (ESLOY) | France | $128.660B | 0.00 |
| Medtronic (MDT) | Ireland | $104.194B | 14.77 |
| Haleon (HLN) | United Kingdom | $50.678B | 28.85 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.121B | 0.00 |
| ResMed (RMD) | United States | $35.889B | 26.96 |
| GE HealthCare Technologies (GEHC) | United States | $32.579B | 15.47 |
| Agilent Technologies (A) | United States | $31.612B | 20.53 |
| Terumo (TRUMY) | Japan | $27.743B | 36.03 |
| Insulet (PODD) | United States | $22.770B | 89.38 |
| Koninklijke Philips (PHG) | Netherlands | $21.553B | 15.49 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.259B | 11.73 |
| Baxter (BAX) | United States | $15.693B | 11.72 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.530B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.236B | 21.70 |
| Lantheus Holdings (LNTH) | United States | $5.132B | 12.95 |
| Prestige Consumer Healthcare (PBH) | United States | $4.168B | 18.62 |
| Perrigo (PRGO) | Ireland | $3.726B | 9.44 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.248B | 14.79 |
| ICU Medical (ICUI) | United States | $3.162B | 23.32 |
| Envista Holdings (NVST) | United States | $3.141B | 26.10 |
| GN Store Nord (GNNDY) | Denmark | $2.200B | 18.22 |
| QuidelOrtho (QDEL) | United States | $2.144B | 14.74 |
| LeMaitre Vascular (LMAT) | United States | $1.830B | 40.91 |
| AtriCure (ATRC) | United States | $1.660B | 0.00 |
| Acuren (TIC) | United States | $1.336B | 0.00 |
| Neogen (NEOG) | United States | $1.326B | 16.97 |
| AdaptHealth (AHCO) | United States | $1.225B | 12.44 |
| Kestra Medical Technologies (KMTS) | United States | $1.174B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.103B | 24.81 |
| BioLife Solutions (BLFS) | United States | $1.062B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.993B | 12.69 |
| InMode (INMD) | Israel | $0.910B | 9.17 |
| CeriBell (CBLL) | United States | $0.621B | 0.00 |
| Evolus (EOLS) | United States | $0.600B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.593B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.563B | 0.00 |
| Valneva SE (VALN) | France | $0.533B | 0.00 |
| Owens & Minor (OMI) | United States | $0.504B | 4.18 |
| Capricor Therapeutics (CAPR) | United States | $0.486B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.453B | 0.00 |
| Surmodics (SRDX) | United States | $0.418B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.342B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.329B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.325B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.324B | 11.91 |
| Aurora Cannabis (ACB) | Canada | $0.310B | 55.20 |
| Viemed Healthcare (VMD) | United States | $0.260B | 21.90 |
| Sanara MedTech (SMTI) | United States | $0.257B | 0.00 |
| ZimVie (ZIMV) | United States | $0.245B | 11.14 |
| Cerus (CERS) | United States | $0.242B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.240B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.236B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.211B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.207B | 0.00 |
| Quanterix (QTRX) | United States | $0.205B | 0.00 |
| Brainsway (BWAY) | Israel | $0.202B | 53.50 |
| Biote (BTMD) | United States | $0.193B | 5.43 |
| Omeros (OMER) | United States | $0.184B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| High Tide (HITI) | Canada | $0.181B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.176B | 14.30 |
| Exagen (XGN) | United States | $0.143B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.135B | 16.62 |
| Jin Medical (ZJYL) | China | $0.119B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.119B | 0.00 |
| Agape ATP (ATPC) | $0.093B | 0.00 | |
| Fonar (FONR) | United States | $0.089B | 11.48 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| MacroGenics (MGNX) | United States | $0.088B | 0.00 |
| Veru (VERU) | United States | $0.077B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.070B | 0.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.060B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| United Health Products (UEEC) | United States | $0.052B | 0.00 |
| Modular Medical (MODD) | United States | $0.047B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.45 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.031B | 41.74 |
| Safety Shot (SHOT) | United States | $0.026B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |